Ginkgo bioworks advances collaboration with merck to improve biologics manufacturing

Boston , nov. 12, 2024 /prnewswire/ -- ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, today announced the completion of the first milestone of a previously announced partnership with merck , known as msd outside of the united states and canada, focused on improving biologic manufacturing. as part of this milestone completion, ginkgo will receive a research milestone payment of $9 million in cash.
DNA Ratings Summary
DNA Quant Ranking